Cargando…
RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer
Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype for which no effective targeted therapies are available. Growing evidence suggests that chemotherapy-resistant cancer cells with stem-like properties (CSC) may repopulate the tumor. The androgen receptor (AR) is expressed in...
Autores principales: | Fernández, Natalia B., Sosa, Sofía M., Roberts, Justin T., Recouvreux, María S., Rocha-Viegas, Luciana, Christenson, Jessica L., Spoelstra, Nicole S., Couto, Facundo L., Raimondi, Ana R., Richer, Jennifer K., Rubinstein, Natalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913961/ https://www.ncbi.nlm.nih.gov/pubmed/36766786 http://dx.doi.org/10.3390/cells12030444 |
Ejemplares similares
-
RUNX1 and FOXP3 interplay regulates expression of breast cancer related genes
por: Recouvreux, María Sol, et al.
Publicado: (2015) -
Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
por: Hanamura, Toru, et al.
Publicado: (2021) -
OR30-5 Androgen-Regulated Secreted Factors Promote Tumorigenesis and Immune Suppression in Breast Cancer
por: Richer, Jennifer, et al.
Publicado: (2022) -
RUNX2: a prognostic biomarker for triple-negative breast cancer?
Publicado: (2014) -
NPC1 Confers Metabolic Flexibility in Triple Negative Breast Cancer
por: O’Neill, Kathleen I., et al.
Publicado: (2022)